127 related articles for article (PubMed ID: 14742225)
1. Plasma pharmacokinetics of sulfadiazine administered twice daily versus four times daily are similar in human immunodeficiency virus-infected patients.
Jordan MK; Burstein AH; Rock-Kress D; Alfaro RM; Pau AK; Kovacs JA; Piscitelli SC
Antimicrob Agents Chemother; 2004 Feb; 48(2):635-7. PubMed ID: 14742225
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and oral bioavailability of sulfadiazine and trimethoprim in broiler chickens.
Baert K; De Baere S; Croubels S; De Backer P
Vet Res Commun; 2003 May; 27(4):301-9. PubMed ID: 12872830
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and bioavailability of sulfadiazine and trimethoprim (trimazin 30%) after oral administration in non-fasted young pigs.
Baert K; De Baere S; Croubels S; Gasthuys F; De Backer P
J Vet Pharmacol Ther; 2001 Aug; 24(4):295-8. PubMed ID: 11555186
[No Abstract] [Full Text] [Related]
4. Pharmacokinetics and bioavailability of sulfadiazine and trimethoprim following intravenous, intramuscular and oral administration in ostriches (Struthio camelus).
Abu-Basha EA; Gehring R; Hantash TM; Al-Shunnaq AF; Idkaidek NM
J Vet Pharmacol Ther; 2009 Jun; 32(3):258-63. PubMed ID: 19646090
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and safety of high-dose and extended-interval regimens of levofloxacin in human immunodeficiency virus-infected patients.
Piscitelli SC; Spooner K; Baird B; Chow AT; Fowler CL; Williams RR; Natarajan J; Masur H; Walker RE
Antimicrob Agents Chemother; 1999 Sep; 43(9):2323-7. PubMed ID: 10471591
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.
Chien SC; Chow AT; Rogge MC; Williams RR; Hendrix CW
Antimicrob Agents Chemother; 1997 Aug; 41(8):1765-9. PubMed ID: 9257757
[TBL] [Abstract][Full Text] [Related]
7. A study of the pharmacokinetics and tissue residues of an oral trimethoprim/sulphadiazine formulation in healthy pigs.
Garwacki S; Lewicki J; Wiechetek M; Grys S; Rutkowski J; Zaremba M
J Vet Pharmacol Ther; 1996 Dec; 19(6):423-30. PubMed ID: 8971670
[TBL] [Abstract][Full Text] [Related]
8. Transdermal delivery and intramuscular injection of trimethoprim/sulphadiazine in sucking piglets.
Sekido T; Kokue E; Shimoda M; Hayama T
Vet Q; 1992; 14(3):85-7. PubMed ID: 1413444
[TBL] [Abstract][Full Text] [Related]
9. Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group.
Podzamczer D; Miró JM; Bolao F; Gatell JM; Cosín J; Sirera G; Domingo P; Laguna F; Santamaría J; Verdejo J
Ann Intern Med; 1995 Aug; 123(3):175-80. PubMed ID: 7598298
[TBL] [Abstract][Full Text] [Related]
10. New simple liquid chromatographic method for the determination of trimethoprim, sulfadiazine and N4-acetylsulfadiazine in plasma of broilers.
Batzias GC; Botsoglou NA; Kotsaki-Kovatsi VP; Kounenis G
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Apr; 769(2):253-9. PubMed ID: 11996491
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, bioavailability and dosage regimen of sulphadiazine (SDZ) in camels (Camelus dromedarius).
Kumar R; Singh AP; Kapoor M; Rai AK
J Vet Pharmacol Ther; 1998 Oct; 21(5):393-9. PubMed ID: 9811441
[TBL] [Abstract][Full Text] [Related]
12. Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patients.
Wood R; Arasteh K; Stellbrink HJ; Teofilo E; Raffi F; Pollard RB; Eron J; Yeo J; Millard J; Wire MB; Naderer OJ
Antimicrob Agents Chemother; 2004 Jan; 48(1):116-23. PubMed ID: 14693528
[TBL] [Abstract][Full Text] [Related]
13. Disposition kinetics and dosage regimen of sulfadiadine in crossbred calves.
Srivastava AK; Chaudhary RK; Raina R
Ann Rech Vet; 1990; 21(3):173-7. PubMed ID: 2389923
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of epiroprim (Ro11-8958), a new dihydrofolate reductase inhibitor, in the treatment of acute Toxoplasma infection in mice.
Martinez A; Allegra CJ; Kovacs JA
Am J Trop Med Hyg; 1996 Mar; 54(3):249-52. PubMed ID: 8600759
[TBL] [Abstract][Full Text] [Related]
15. Distribution of orally administered trimethoprim and sulfadiazine into noninfected subcutaneous tissue chambers in adult ponies.
van Duijkeren E; Ensink JM; Meijer LA
J Vet Pharmacol Ther; 2002 Aug; 25(4):273-7. PubMed ID: 12213115
[TBL] [Abstract][Full Text] [Related]
16. The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals.
van Heeswijk RP; Veldkamp AI; Mulder JW; Meenhorst PL; Wit FW; Lange JM; Danner SA; Foudraine NA; Kwakkelstein MO; Reiss P; Beijnen JH; Hoetelmans RM
AIDS; 2000 May; 14(8):F77-82. PubMed ID: 10853971
[TBL] [Abstract][Full Text] [Related]
17. Repeated administration of trimethoprim/sulfadiazine in the horse--pharmacokinetics, plasma protein binding and influence on the intestinal microflora.
Gustafsson A; Båverud V; Franklin A; Gunnarsson A; Ogren G; Ingvast-Larsson C
J Vet Pharmacol Ther; 1999 Feb; 22(1):20-6. PubMed ID: 10211713
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, safety and tolerability of moxifloxacin, a novel 8-methoxyfluoroquinolone, after repeated oral administration.
Stass H; Kubitza D; Schühly U
Clin Pharmacokinet; 2001; 40 Suppl 1():1-9. PubMed ID: 11352436
[TBL] [Abstract][Full Text] [Related]
19. Oral absorption profiles of sulfonamides in Shiba goats: a comparison among sulfadimidine, sulfadiazine and sulfanilamide.
Elbadawy M; Ishihara Y; Aboubakr M; Sasaki K; Shimoda M
J Vet Med Sci; 2016 Jul; 78(6):1025-9. PubMed ID: 27010464
[TBL] [Abstract][Full Text] [Related]
20. Serum and skin concentrations after multiple-dose oral administration of trimethoprim-sulfadiazine in dogs.
Pohlenz-Zertuche HO; Brown MP; Gronwall R; Kunkle GA; Merritt K
Am J Vet Res; 1992 Jul; 53(7):1273-6. PubMed ID: 1497202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
